Femme et Homme
- | Pays :
- India
- United States
- Bosnia and Herzegovina
- Les 5 autres...
- | Organes : -
- | Spécialités : -
Extrait
This double-blind, placebo-controlled, dose-finding study is designed to identify the lowest AGI-1067 dose that improves glycemic control as measured by HbA1c and fasting glucose in subjects with Type 2 diabetes mellitus. Glycemic control will be measured during a 6-month treatment period in subjects who are on 1 or no antidiabetic drugs
Critère d'inclusion
- diabetes